Clik here to view.
Samsara Therapeutics Closes Seed Round Led by Apollo Ventures
NEW YORK & HAMBURG, Germany Samsara Therapeutics, Inc. (“Samsara,”) a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular...
View ArticleClik here to view.
Gain Therapeuticsがパーキンソン病研究の有力財団からパーキンソン病向けの当社専有の非競合的分子シャペロンを発展させるための助成受領を発表
スイス・ルガーノ & スペイン・バルセロナ （ビジネスワイヤ） — GT Gain Therapeutics...
View ArticleClik here to view.
Alexion Employees Raise Hands to Raise Awareness and #RallyforRare on Rare...
BOSTON Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) is honored to support Rare Disease Day 2019 with the launch of #RallyforRare, a global social media campaign that aims to raise awareness of rare...
View ArticleClik here to view.
PanTheryx Presents Positive Results from Two New DiaResQ Studies at its 2019...
BANGKOK PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide range of serious GI microbiome related health conditions, announced today the...
View ArticleClik here to view.
Avita Medical Announces Collaboration with COSMOTEC, an M3 Group Company, to...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to...
View ArticleClik here to view.
ReForm Biologics Announces Collaboration Agreement with Astellas Pharma Inc.
WOBURN, Mass. ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a...
View ArticleClik here to view.
SanBio to Announce the Results of a Phase 2 STEMTRA Trial Regarding the Use...
MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.) (TOKYO: 4592), a scientific leader in regenerative medicine for neurological disorders, today announced its plan to make...
View ArticleClik here to view.
ReForm Biologicsがアステラス製薬との協業契約を発表
米マサチューセッツ州ウーバン (ビジネスワイヤ) — 薬物送達／製造を改善する革新的なバイオ医薬品製造法を開発する非公開製薬技術企業ReForm Biologicsは本日、アステラス製薬株式会社（TSE:...
View ArticleClik here to view.
Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs....
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from the Phase 3b head-to-head VARSITY study which demonstrated that the gut-selective...
View ArticleClik here to view.
AVITA Medical Announces Ten RECELL® System Presentations at the American Burn...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today the schedule for ten presentations describing clinical and cost-savings advantages of the RECELL®...
View ArticleClik here to view.
Enjin Mobilizes 20 Million Gamers & Blockchain to Help Humans Live Longer
SINGAPORE Enjin, an information technology company focused on online gaming and the cryptocurrency sector, has been at the forefront of blockchain innovation for over a decade. Unlike the vast...
View ArticleClik here to view.
Dental Monitoring与Vitruvian合作，加快其创新人工智能解决方案的全球扩张
巴黎 (美国商业资讯) — Dental Monitoring (“DM”)是牙科及正畸领域人工智能解决方案优质套件的提供商，该公司已获得领先的成长投资者Vitruvian Partners提供的一轮4500万欧元的注资，用于加快其全球扩张。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
オンコイミュニティー、機械学習を使用した新生抗原予測技術の臨床使用に対しCE-IVDマークを取得した初の企業に
ノルウェー・オスロ （ビジネスワイヤ） — オンコイミュニティーは、機械学習を使用した新生抗原予測技術の臨床使用に対しCE-IVDマークを取得した初の企業になりました。今回の品質保証認定は、個別化がんワクチン／細胞療法のデザインへの新生抗原予測技術の使用の水準を高める上で重要な前進となります。...
View ArticleClik here to view.
BioChain Responds to Epigenomics’ Unilateral Termination of License Contract
NEWARK, Calif. BioChain, a US-based company, said today Epigenomics AG of Germany seriously violated the terms of an ongoing licensing contract by publicly announcing on March 6, 2019 the unilateral...
View ArticleClik here to view.
AVITA Medical to Present at Cowen and Company Health Care Conference
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that management will present at the Cowen and Company 39th...
View ArticleClik here to view.
Flow Pharma, Inc.与OncoImmunity AS合作开发FlowVax™个体化癌症疫苗
挪威奥斯陆 Flow Pharma Inc是旧金山湾区一家专注于开发个体化癌症疫苗的生物技术公司，该公司今天宣布与挪威生物信息学公司OncoImmunity AS达成一项合作。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20190314005283/zh-CN/...
View ArticleClik here to view.
フロー・ファーマとオンコイミュニティーがFlowVaxTM個別化がんワクチンの開発で提携
ノルウェー・オスロ （ビジネスワイヤ） — サンフランシスコ・ベイエリアのバイオテクノロジー企業として個別化がんワクチンの開発に傾注しているフロー・ファーマは本日、ノルウェーのバイオインフォマティクス企業オンコイミュニティーとの協業を発表しました。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：...
View ArticleClik here to view.
Octapharma Group公布强劲的2018年业绩
瑞士图恩 (美国商业资讯)–Octapharma首席执行官兼董事长Wolfgang Marguerre在评价集团经营结果时表示：“2018年，我们继续推动公司许多产品的增长。尤其值得高兴的是，我们的新型纤维蛋白原浓缩物fibryga®在瑞士获得重要的监管批准，我们的新型10%...
View ArticleClik here to view.
Blackstone Signs Definitive Agreement to Acquire AYUMI Pharmaceutical
TOKYO Blackstone (NYSE: BX) announced today that private equity funds managed by Blackstone (“Blackstone”) have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation...
View ArticleClik here to view.
HKTDC Hong Kong International Medical and Healthcare Fair Presents...
HONG KONG Hong Kong, The HKTDC Hong Kong International Medical and Healthcare Fair (Medical Fair) will take place at the Hong Kong Convention and Exhibition Centre (HKCEC) from 14 to 16 May....
View Article